Stage IV Merkel Cell Carcinoma
5 clinical trials · Condition
◉ Watch Stage IV Merkel Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer (NCT04670445) | Massachusetts General Hospital | 2021-01-23 |
| Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor (NCT02831179) | Vanderbilt-Ingram Cancer Center | 2017-12-01 |
| QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC) (NCT02465957) | ImmunityBio, Inc. | 2015-09-24 |
| Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma (NCT01758458) | Fred Hutchinson Cancer Center | 2013-02-01 |
| Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma (NCT01204476) | National Cancer Institute (NCI) | 2010-10-01 |
Track Stage IV Merkel Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.